The RE(ACT) Congress – International Congress on Research of Rare and Orphan Diseases was initiated in 2012 by the BLACKSWAN Foundation to create a human platform to scale up scientific cooperation on rare and orphan disease.
In its three editions, the RE(ACT) Congress brought together almost 1,500 people to discuss research into rare diseases and the development of active substances to treat them. What made the congress unique was the interdisciplinary collaboration. Scientists from different disciplines – stem cell researchers, geneticists, biochemists, clinicians and pharmacists – exchanged information with patient organizations.
The congress aims to bring together world leaders and young scientist from a variety of breaking through scientific field to present cutting edge research, to discuss results and to exchange ideas. Moreover, many patients and patient organization, which are committed in research, will be present to share their experience.
The 4th edition is co-organized in collaboration with E-RARE ERA-NET for research programs on rare diseases.
It is a pleasure to invite you to attend the RE(ACT) Congress 2018 that will be held at the Istituto Ortopedico Rizzoli in Bologna, Italy, from 7th to 10th March 2018, a superb setting for stimulating learning, exchanges and networking.
Registration will open in June 2017, please subscribe at our newsletter to be updated about the congress and our activities.
|Dr. Olivier Menzel, PhD, MBA
||Dr. Daria Julkowska
|President and founder